Publications

Frangos S, Buscombe JR. Why should we be concerned about a “g”?. Eur J Nucl Med Mol Imaging 2019;46:519.

Frangos S, Giannoula E, Buscombe JR, Iakovou I. Theragnostics: A neologism that generates schism. The Hellenic thesis. J Nucl Med 2021; 62.

Frangos S, Giannoula E, Exadaktylou P, Iakovou I. Applying thyroid cancer guidelines: a difficult task. Clin Transl Imaging 2021; 9:203-207

Frangos S, Hustinx R, Boubaker A, Varetto T, Prior JO, Siroos M, Maffioli L. The Future of the Past Is the Present: The Role of the UEMS/EBNM in the Current Challenge of Educating Nuclear Medicine Specialists. J Nucl Med 2018;59:396-398.

Frangos S, Iakovou IP, Marlowe RJ, Eftychiou N, Patsali L, Vanezi A, et al. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):185-189.

Frangos S, Iakovou IP, Marlowe RJ, Eftychiou N, Patsali L, Vanezi A, Savva A, Mpalaris V, Giannoula EI. Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2045-55.

Frangos S, Knapp WH; EANM Executive Committee. European Association of Nuclear Medicine: adapt the present, shape the future. Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):590-1.

Frangos S. To be "Padhied": A Neologism to Show the Pathos of Prof. Ajit Padhy for Nuclear Medicine. World J Nucl Med. 2014 Jan;13(1):1-2. doi: 10.4103/1450-1147.138566. PMID: 25191104; PMCID: PMC4149762.

Frangos, S., Buscombe, J. Prof. Ajit Padhy MBBS, MNAMS, FAMS. Eur J Nucl Med Mol Imaging 41, 185–186 (2014). https://doi.org/10.1007/s00259-013-2567-8

Frangos, S., Haralambous, H., Michael, K., & Economides, P. A. (2022). Subacute thyroiditis after the third dose of the COVID-19 mRNA vaccine. Case report. Hellenic journal of nuclear medicine, 25(2), 210-212.

Michael, K., Frangos, S., Iakovou, I., Lontos, A., Demosthenous, G., & Parpottas, Y. (2024). The Impact of Dual and Triple Energy Window Scatter Correction on I-123 Postsurgical Thyroid SPECT/CT Imaging Using a Phantom with Small Sizes of Thyroid Remnants. Life, 14(1), 113.

Michael, K., Hadjiconstanti, A., Lontos, A., Demosthenous, G., Frangos, S., & Parpottas, Y. (2023). A Neck-Thyroid Phantom with Small Sizes of Thyroid Remnants for Postsurgical I-123 and I-131 SPECT/CT Imaging. Life, 13(4), 961.

Demetriou, E., Fokou, M., Frangos, S., Papageorgis, P., Economides, P. A., & Economides, A. (2023). Thyroid Nodules and Obesity. Life, 13(6), 1292.

Modoni S, Frangos S, Iakovou I, Boero M, Mansi L. Theragnostics before we found its name. Q J Nucl Med Mol Imaging 2021;65:000-000. DOI : 10.23736/S1824-4785.21.03410-5

Charalambous A, Frangos S, Talias M. A randomized controlled trial for the use of thymus honey in decreasing salivary gland damage following radioiodine therapy for thyroid cancer: research protocol. J Adv Nurs. 2014 Jul;70(7):1663-71.

Charalambous HC, Demetriou A, Frangos S, Pavlou P. Increase in thyroid cancer (TC) incidence in Cyprus: Overdiagnosis or true increase of clinically relevant TC?. Ann Oncol 2018;29.

Christou A, Papastavrou E, Merkouris A, Frangos S, Tamana P, Charalambous A. Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review. Evid Based Complement Alternat Med. 2016;2016:6795076.

Cutler CS, Bailey E, Kumar V, Schwarz SW, Bom H-S, Hatazawa J, Paez D, Orellana P, Louw L, Mut F, Kato H, Chiti A, Savvas Frangos, Fahey F, Dillehay G, Oh SJ, Lee DS, Lee S-T, Nunez-Miller R, Bandhopadhyaya G, Pradhan PK, Scott AM. Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project. J Nucl Med 2021; 62:422-430.

Dizdarevic S, Tulchinsky M, McCready VR, Mihailovic J, Vinjamuri S, Buscombe JR, Lee ST, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I; WARMTH Thyroid Group. The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma. World J Nucl Med. 2019;18:123-126.

Fanis P, Skordis N, Frangos S. et al. Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect. J Endocrinol Invest 2018; 41:1149–1157.

Giannoula E, Melidis C, Frangos S, Papadopoulos N, Koutsouki G, Iakovou I. Ecological Study on Thyroid Cancer Incidence and Mortality in Association with European Union Member States’ Air Pollution. Int J Environ Res 2021;18:153.

Hadjiconstanti A, Michael K, Leontiou T, Lontos A, Frangos S, Demosthenous G, Lyra M, Parpottas Y. The impact of two scatter correction methods on I-131 AC-SPECT images using an anthropomorphic phantom with variable sizes of thyroid remnants. Proceedings by ACM: ICBBE2020, 13pp, paper ID: N0032, (ISBN: 978-1-4503-8822-1).

Iakovou I, Giannoula E, Gkantaifi A, Levva S, Frangos S. Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals. European J Hybrid Imaging 2018; 2:20.

Lee DS, Trujillo PB, Frangos S. First steps in an uncharted territory by WFNMB. Eur J Nucl Med Mol Imaging 2019;46:524-530.

Papaioannou C, Lamnisos D, Kyriacou K, Lyssiotis T, Constantinides V, Frangos S, Economides A, Economides PA. Lymph node metastasis and extrathyroidal extension in papillary thyroid microcarcinoma in Cyprus: Suspicious subcentimeter nodules should undergo FNA when multifocality is suspected", J Thyroid Res 2020.

Strauss, Ludwig G.,Savvas Frangos, and Antonia Dimitrakopoulou-Strauss. "Response of calcitonin levels due to positron emission tomography with (18) F-FDG." Hellenic journal of nuclear medicine 15.3 (2012): 251.

Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M; EANM and the EANM Thyroid Committee. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90.

Vassiliou V, Andreopoulos D, Frangos S, Tselis N, Giannopoulou E, Lutz S. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):632-45.

Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee. Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1001-5.

Books and Book Chapters

E. Bombardieri and S. Frangos: Nuclear medicine: fusing the ideas of Democritus and Hippocrates. Anniversary book of 25 years of the EANM.

Frangos, S., Iakovou, I. (2018). New Approaches in the Management of Thyroid Cancer. In: Bombardieri, E., Seregni, E., Evangelista, L., Chiesa, C., Chiti, A. (eds) Clinical Applications of Nuclear Medicine Targeted Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-63067-0_5

Frangos, S., Giannoula, E., Exadaktylou, P., Michael, K., & Iakovou, I. (2021). Collimators for γ cameras. (Book Chapter Signore - Nuclear Medicine and Molecular Imaging)

Frangos, S., Michael, K., Iakovou I., Giannoula, E. & Exadaktylou, P. (2021). The Anger’s camera (Book Chapter Signore - Nuclear Medicine and Molecular Imaging)